*Coloplast slips on negative broker comments. *Telecom Italia up on report Vivendi to increase stake. Danish medical equipment maker Coloplast was the biggest faller after a string of banks cut their target price for the stock, a day after the company lowered its guidance for 2014/ 15. Its shares fell 2.8 percent, having dropped 7.8 percent in the previous session.» Read More
Pavle Sabic, director of Credit Market Development at S&P Capital IQ, discusses the healthcare sector in terms of investing.
CNBC Crowdfinance Tech Index lists the largest capital commitments raised by 25 private U.S. tech companies on Crowdnetic’s data platform.
This list represents the largest capital commitments raised by private U.S. companies actively listed on equity crowdfunding platforms.
Anmol Madan, Ginger.io CEO, discusses how his company's technology helps track a patient's well-being.
George Freeman MP, minister of life sciences in the U.K., says there's been a "resurgence" for life sciences and healthcare investment.
Johnson & Johnson reported lower-than-expected sales as a stronger dollar offset higher sales of the Band-Aid maker's new drugs and older treatments.
Merck reported earnings that beat analysts' expectations, but global sales dropped amid patent expirations and a drop in sales of its hep C drugs.
There are new inventions out there to solve some of the oldest problems for business travelers.
Shares of Malaysia's latex glove makers have had a tough year so far, but some analysts expect panic over Africa's Ebola outbreak may spur gains.
As the global population ages, some see investment opportunities in somewhat ghoulish bets the rates of cancer and other illnesses will rise.
Shire has hired investment bank Citi as an adviser following a wave of deals in the healthcare sector.
Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.
Profile of 27-year-old Ethan Lewis, who has been creating products to sell to his fellow diabetics.
The Cefaly device uses a mild electric current to prevent migraines.
P&G is bringing the dentist into your bathroom a smartphone-connected toothbrush, a device that gives personalized advice to help people improve their brushing.
Johnson & Johnson and its subsidiaries were accused of promoting powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients.
The family of Henrietta lacks, whose immortal cells made billions in medical research, won an ethical victory when they were given some power over HeLa cell information.
Henry Schein is the world's largest health care products and services company for doctors, dentists, and vets, and the stock has been on a tear. Stanley Bergman, Henry Schein chairman and CEO, shares where he sees dental and health care headed.
Johnson & Johnson reported higher-than-expected earnings as strong sales of prescription drugs and medical devices more than offset anemic growth of its consumer products.
Obama administration to scrap age restrictions on the sale of morning-after pills, making the emergency contraception available to women and girls of any age without a prescription.